Matches in Nanopublications for { ?s ?p "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP140562.RAWMWj0chU9NtfpzjSPcdfJY8vd3dd8OZi9Pr2_e1BD2w130_assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140562.RAWMWj0chU9NtfpzjSPcdfJY8vd3dd8OZi9Pr2_e1BD2w130_provenance.
- NP109691.RAA55I6dNqppP2mqMkq9wW4a4sjcQoFRwDaKXrA2JcAfM130_assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109691.RAA55I6dNqppP2mqMkq9wW4a4sjcQoFRwDaKXrA2JcAfM130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP140564.RAtUvXi1iXhQOtcmKIldYE84JRFOhWKzWTvpqMN_4LJVo130_assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140564.RAtUvXi1iXhQOtcmKIldYE84JRFOhWKzWTvpqMN_4LJVo130_provenance.
- NP109669.RAxv1ov1tRwAZHluoRp7kJPQlqs2HwhubzoT59tm8OtcE130_assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109669.RAxv1ov1tRwAZHluoRp7kJPQlqs2HwhubzoT59tm8OtcE130_provenance.